1. The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts;Blood,2013
2. Pricing for orphan drugs will the market bear what society cannot;O'Sullivan;Journal of American Medical Association,2013
3. Public Summary Document. Ivacaftor, tablet, 150mg, Kalydeco® – July;Pharmaceutical Benefit Advisory Committee,2013
4. Public Summary Document. Ivacaftor, tablet, 150mg, Kalydeco® – November;Pharmaceutical Benefit Advisory Committee,2013
5. Annual report 2012–2013;Australian Government, Department of Health and Ageing,2013